National Comprehensive Cancer Network

Educational Events & Programs

NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business

Wednesday, March 11, 2015
8:20 AM – 2:15 PM
(Breakfast and registration begin at 7:30 AM)

The Diplomat
Hollywood, FL

Overview

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell.


Moderator:

Clifford Goodman, PhD
Senior Vice President
The Lewin Group


7:30 – 8:15 AM
Breakfast and Registration

8:20 – 8:25 AM
Welcome
C. Lyn Fitzgerald, MJ
Vice President, U.S & Global Development
National Comprehensive Cancer Network

8:30 – 10:00 AM
Module I:
Meet the New NCCN Member Institutions

Confirmed Panelists:
Ned Groves, MPS, PMP
Associate Director for Cancer Practice Administration
Mayo Clinic Cancer Center

Abe Lopman, MBA
Senior Vice President, Operations
Executive Director, Smilow Cancer Hospital
Yale Cancer Center/Smilow Cancer Hospital

Thomas Lynch, Jr., MD
Director, Yale Cancer Center
Physician-in-Chief, Smilow Cancer Hospital
Jonathan and Richard Sackler Professor of Medicine
Yale Cancer Center/Smilow Cancer Hospital

Barbara Parker, MD
Deputy Director, Clinical Affairs
Medical Director, Oncology Services
Professor of Clinical Medicine
UC San Diego Moores Cancer Center

W. Thomas Purcell, MD, MBA
Associate Director for Clinical Services
Executive Medical Director, Oncology Services
University of Colorado Cancer Center

Samuel M. Silver, MD, PhD, MACP
Assistant Dean for Research
Professor, Internal Medicine/Hematology-Oncology
University of Michigan Comprehensive Cancer Center       

10:00 – 10:10 AM
Break

10:15 – 11:40 AM
Module II:
Big Data: Current Trends in the Collection and Utilization of Real World Data in Advancing Cancer Care

Confirmed Panelists:
Amy Abernethy, MD, PhD
Chief Medical Officer, SVP
Flatiron Health, Inc.

Linda House, BSN, MS
Executive Vice President of External Affairs
Cancer Support Community

Alexander Liede, MSc, PhD
Director, Cancer Epidemiology
Center for Observational Research, Amgen, Inc.

Robert S. Merkel, MBA
Healthcare & Life Sciences Leader
IBM Watson Group

Robert Miller, MD
Senior Director for Quality and Guidelines, Medical Director for CancerLinQ
ASCO

11:45 AM – 12:25 PM
Lunch

12:30 – 2:00 PM
Module III:
Meet the NCCN Guidelines Panel Experts: 20 years of Guidelines Development

Confirmed Panelists:
Al B. Benson, III, MD
Professor of Medicine and Associate Director for Clinical Investigations
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chair, NCCN Guidelines Panels for Colon and Rectal Cancers

Robert W. Carlson, MD 
Chief Executive Officer
National Comprehensive Cancer Network
Founding Chair, NCCN Guidelines Panel for Breast Cancer

David S. Ettinger, MD
Alex Grass Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chair, NCCN Guidelines for NSCLC

James L. Mohler, MD
Associate Director and Senior-Vice President for Translational Research, Chair, Department of Urology, and Professor of Oncology
Roswell Park Cancer Institute
Chair, NCCN Guidelines Panel for Prostate Cancer

Marcus Neubauer, MD
Medical Director, Oncology Services
McKesson Corporation

Margaret R. O'Donnell, MD
Clinical Professor and Associate Clinical Director, Hematology & Hematopoietic Cell Transplantation
Clinical Professor
City of Hope Comprehensive Cancer Center
Chair, NCCN Guidelines for AML

2:00 – 2:15 PM
Closing Remarks         
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*Subject to change.       

Program Location:

The Diplomat
3555 South Ocean Drive
Hollywood, Florida 33019

Tuition Information:

   
  By 2.2.2015 After 2.2.2015
Academy Alumni $795 $895
Industry Registrants $1,195 $1,295
NCCN Corporate Council Members $1,095 $1,195
Ten or more people from the same company $1,050 $1,050

 

Accomodations:

We currently have a room block at The Diplomat for the night of Tuesday, March 10, 2015.  The room rate is $329.00 plus 11% tax (total $365.19).  Early booking is suggested.  Any requests received after February 2, 2015 will be contacted by NCCN to discuss availability.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell.


License NCCN Academy Video Modules!

Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.

Customize your own NCCN Academy curriculum.


NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.